Skip to content

About

About Tom Ling

I’m an experienced data analyst with a background in pharmaceutical and healthcare market research and consulting. I’m currently working in a permanent role as a data analyst for Ekco, a Dublin-based cloud computing company with offices in the UK, Ireland, the Netherlands, South Africa and Malaysia. I also offer ad-hoc research, analysis and copyediting/proofreading services (contact me on LinkedIn for enquiries).

My journey (so far)

  • I was born in Malaysia and went to school in Scotland and Wales. My interests were oriented towards mathematics, science and information technology. For example, I taught myself to write simple programs and games in MSWLogo, and ran a weekly maths competition with a school friend (we still keep in touch!).
  • In 2009 I graduated from the University of Cambridge as a preclinical medicine graduate. I went on to train in clinical medicine at St. George’s, University of London (SGUL). As a medical student, I was particularly technically focused; I kept my study notes in a personal wiki powered by the same software as Wikipedia. (To my knowledge I was the only medical student doing this at the time.)
  • I left SGUL in 2013 to join Visiongain, a business intelligence provider, where I worked as a pharmaceutical industry analyst and then a senior analyst and consultant. In this role I wrote reports and forecasts covering pharmaceutical and medical devices markets.
  • In 2015 I joined IMS Health as an Analyst and later became a Senior Analyst. I wrote market reports and forecasts of the markets for central nervous system therapies such as Alzheimer’s disease and multiple sclerosis.
  • In 2017 I completed my BSc in Economics and Mathematical Sciences from the Open University.
  • Also in 2017, I joined the Analytics Center of Excellence within IQVIA (the new parent company of IMS Health, following a merger between IMS Health and Quintiles). In my new role as Consultant, I designed and implemented the methodology used by the team to estimate the distribution of patient populations among UK hospitals, based on IQVIA data and external data sources. These analyses were used to speed up recruitment into clinical trials and contributed to over 330m USD in new business awarded to IQVIA.
  • In 2019 I left IQVIA, taking a career break that combined travel, the founding of my contractor company, Capalytic (active 2019-2024); and self-directed learning in data science tools and technologies.
  • In 2020 I joined Frontier Technology, a cloud computing provider in London, as a Data Analyst. Frontier Technology was acquired by Ekco in 2022, where I remain in a data analytics role as part of the Development team.

My interests

In my spare time:

Enquiries

To discuss opportunities, contact me on LinkedIn.